Copyright © 2017 All rights reserved

“Newly listed IPO stock discussing patent pending CBD Sun Care”

“I've been using CaniSun sunscreen and I love the product. This is an easy endorsement for someone who's in the sun as much as i am.”

Our Opinion

Based on the prospects uncovered by JUPW products in clinical testing and considering the company's market capitalization, JUPW offers extensive upside for potential investors

Get JUPW Updates Sent To Your Phone

More About JUPW

Here's what you should know about Jupiter Wellness:

Jupiter Wellness inc.

(JUPW) is a wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol via a collection of convenient consumer products. its brands include CaniSun, CaniSkin, CaniDermRx and CaniSweet.

(JUPW) is seeking opportunities to expand into innovative CBD based products that can be a major long-term profitability addition for the comopany with sustainable cash flow and extensive investor returns

(JUPW) will be at the FOREFRONT of CBD-based innovation in Medicare.

JUPW Develops (CBD) based skincare, and health products

CBD-based skincare products that provide solutions to skin cancer, burns, sores, and herpes. It's brands include CaniSun, CaniSkin, CaniDermRx and CaniSweet.

JUPW initiates clinical study of CaniSun for the treatment of (Skin Cancer)

CaniSun is an over-the-counter product, which is an effective sunscreen that may act as a prophylactic treatment to prevent AK from occurring or to inhibit its progression into squamous cell carcinoma (skin cancer). 

3 reasons to put JUPW in your portfolio:

1. JUPW is a global leader in an industry worth $73.6 Billion as projected by Forbes by the year 2027.

2. JUPW is set for extensive growth thanks to cutting-edge cannabidoil treatment transforming the therapeutic industry. Jupiter Wellness has a number of products in final-stage trials. 

3. The trailblazing success of leading CBD companies (like Green roads and Charlotte's Web with YoY Revenue growth of 36%) point to a rapidly growing market.

JUPW presents a compelling buying opportunity for investors.

You are the first to hear of JUPW as they recently did an IPO in October, 2020. This is an under the radar, major investment opportunity for you to profit.

Favorable Projections

The CBD product industry is inclined to grow with increasing waves of legalization through multiple states. The favorable industry projections  ($74.6 Billion by 2027) signal a major growth opportunity for profit.

Ready To Make Money With (JUPW)?

Always do your own research on (JUPW).

Ready To Make Money With (MOCI)?

Always do your own research on (MOCI). To proceed.... Click on any of these online brokerages below or call your broker.



Ready To Make Money With JUPW?

Always do your own research on (JUPW). 

This website/newsletter is owned, operated and edited by Stellar Partners  LLC.  Any wording found in this e-mail or disclaimer referencing to “I” or “we” or “our” or “Stellar Partners” refers to Stellar Partners LLC.  This webpage/newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote small public companies.  By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here. Stellar Partners business model is to receive financial compensation to promote public companies. Pursuant to an agreement between Stellar Partners LLC and Penzance LLC (a non affiliated 3rd party), Stellar Partners has been hired for a period beginning on 4/12/22 and ending on 5/12/22 to conduct investor relations advertising and marketing and publicly disseminate information about (jupw) via Website, Email and SMS. We have been paid two hundred thousand dollars via bank wire transfer. We expect to receive additional compensation as the investor awareness continues. We own zero shares of (jupw). This compensation is a major conflict of interest in our ability to be unbiased regarding. Therefore, this communication should be viewed as a commercial advertisement only. We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices.  Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. Our emails may contain forward-looking statements, which are not guaranteed to materialize due to a variety of factors.

We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Stellar Partners often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at


This $1.01 Nasdaq stock may soar. Here's why.

This $1.14 Nasdaq stock may soar. Here's why

Nasdaq IPO:


*Available on Robinhood

Products endorsed by Ernie Els